Antiphlamine Active Roll Patch (Pelvinac)
Felbinac 17.5mg
Patch · OTC medication
Yuhan Corporation
MFDS item code 201706996 · Notified 2017.09.06
Relief of joint and muscle pain, including osteoarthritis
This medication is used for the relief of symptoms related to osteoarthritis, adhesive capsulitis, tendinitis and paratendinitis, lateral epicondylitis (tennis elbow), muscle pain, as well as swelling and pain following trauma.
Cut to an appropriate length, remove the release film from the adhesive side, and apply to the affected area twice a day.
This medication contains the active ingredient Pelvinac, which should not be used by certain patients. Patients who have experienced allergic reactions to this medication, its components, or other Pelvinac formulations should not use this medication. Additionally, patients who have had asthma attacks after using aspirin or other non-steroidal anti-inflammatory drugs should exercise caution when using this medication as it may worsen asthma symptoms. Patients who experienced urticaria or acute rhinitis symptoms caused by aspirin or other non-steroidal anti-inflammatory drugs should also refrain from using this medication. Patients with bronchial asthma should use this medication cautiously due to the risk of asthma attacks. This medication may cause symptoms such as itching, red spots, erythema, dermatitis, contact dermatitis, and, rarely, irritation or blisters on the skin. If these symptoms are severe, use should be discontinued immediately. This medication does not directly treat the cause of inflammation or pain but helps alleviate symptoms, which should be understood before use. When using this medication on inflamed areas accompanied by skin infections, it should be used alongside antibiotics or antifungals to prevent the infection from worsening, and the patient’s condition should be monitored closely. In chronic conditions such as osteoarthritis, other treatment methods should also be considered in addition to drug therapy, and the patient's condition should be monitored carefully for the occurrence of side effects. During the later stages of pregnancy, this medication may cause abnormal labor or delayed delivery, thus it should not be used by pregnant women, women who may become pregnant, or nursing mothers. Safety in pediatric patients has not been sufficiently established, hence caution is required due to limited use experience.
Urticaria, asthma attacks
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and kept at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.
A roll-type patch coated with a colorless and transparent adhesive substance on a release film, covering a solid surface.
56 patches per roll
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Felbinac 17.5mg
Patch · OTC medication
Yuhan Corporation
Felbinac 58.5mg
OTC medication
DaeHwa Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Shin Shin Pharmaceutical Co., Ltd.
Felbinac 48mg
OTC medication
TDS Pharm Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Hyundai Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
JW Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Boryung Pharmaceutical Co., Ltd.
Felbinac 35mg
Patch · OTC medication
Yuhan Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.